Latest Headlines

  1. ISPE Announces 2025 Facility Of The Year Award Cateogry Winners 5/16/2025

    We are thrilled to unveil the exceptional projects selected as category winners for the 2025 ISPE Facility of the Year Awards (FOYA). These distinguished companies were selected not only for their outstanding achievements in engineering and design but also for their commendable contributions to their communities and profound impact on human lives.

  2. SK pharmteco Expands Stability Storage Capacity In California To Support Small Molecule Drug Substance And Drug Product Programs 5/15/2025

    SK pharmteco, a global contract development and manufacturing organization (CDMO), announces the expansion of its stability storage capacity at its El Dorado Hills, California facility.

  3. CDMO Piramal Pharma Solutions Announces $90 Million Investment Into US Manufacturing Facilities 5/14/2025
  4. Ratio Therapeutics to Construct New Radiopharmaceutical Manufacturing 5/14/2025

    Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced that it entered into an agreement with the Medical Innovation Technology Management division of Wasatch Group to partner and construct a state-of-the-art radiopharmaceutical research and manufacturing facility in Salt Lake City, Utah, anticipated to be fully operational in the second half of 2027.

  5. ISPE Announces 2025 Facility Of The Year Awards (FOYA) Category Winners, Celebrating FOYA's 20th Anniversary Year 5/13/2025

    FOYA Judges name six category winners plus two honorable mentions at the 2025 ISPE Europe Annual Conference in London, United Kingdom (UK)..

  6. Genentech Announces Significant Investment For New Fill/Finish Drug Manufacturing Facility In North Carolina 5/12/2025

    Genentech, a member of the Roche Group based in Switzerland, has announced plans to invest $700 million in Holly Springs to establish a new high-volume fill/finish manufacturing facility.

  7. Gilead Announces $32 Billion Investment Into US Drug Manufacturing 5/8/2025

    Gilead Sciences is committed to advancing world-class science and driving innovation — with the United States at the heart of our operations. Today, our U.S. R&D and manufacturing footprint is our largest globally. Our U.S. R&D and manufacturing investments in the U.S. will create $43 billion in value to the U.S. economy over the next five years through direct capital investment and job creation. This comprehensive investment further bolsters Gilead’s domestic research, development, and manufacturing capabilities while advancing the company’s mission to discover and develop life-changing medicines.

  8. Vetter Prioritizes Continuity And Action In Its Sustainability Efforts 5/6/2025

    Vetter, a leading global contract development and manufacturing organization (CDMO) published its fourth annual sustainability report. The report shows that the family-owned business is actively pursuing ambitious sustainability goals in climate protection, social responsibility, and business operations in a successful manner.

  9. 3P innovation Launches Next-Generation DPI Filling Technology For Novel Inhalation Therapeutics 5/1/2025

    Patent expiry of original product enables 3P innovation to design enhanced equivalent DPI filling system for developers and CMOs.

  10. AST Celebrates 60 Years Of Excellence In Innovation And Looks To The Future Of Drug Product Manufacturing 5/1/2025

    AST marked the launch of its 60th anniversary year at INTERPHEX 2025, using the prestigious industry event as a springboard to highlight six decades of innovation. Building on the momentum of being named “Best in Show” at INTERPHEX 2024, AST entered its 60th anniversary receiving another reputable honor: the INTERPHEX Efficiency Champion award. This back-to-back recognition highlights not only AST’s legacy of innovation but also its forward-looking approach to advancing excellence across the industry.